Huateng Pharma Supplies Some Intermediates of CDK4/6 Inhibitors for Treatment of Advanced Breast Cancer
Hunan, China, 2023-Jul-15 — /EPR Network/ — Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes [read full press release…]
